Contents01MethodologyRead more02Key FindingsRead more03Chapter 1Digital transformation and AI/ML implementationRead more04Blue YonderRealising the full potential of artificial intelligence in pharmaceutical supply chains: Why AI without a solid network foundation will failRead more05Chapter 2Sustainability and net-zero targetsRead more06project44AI in pharma supply chains: From visibility to predictive resilienceRead more07Chapter 3Building an AI-fuelled supplier collaboration strategyRead more08ConclusionRead more09Key SuggestionsRead more10About usRead moreContributorsShirell JamesVice PresidentBlue YonderFollow ShirellMarvin SchusterStrategic Account Executive, Pharmaproject44Follow MarvinToby KeechSVP Sales, EMEAproject44Follow TobyStefano ChieiDirector Operations EMEA/EEAdvanced BionicsFollow StefanoDavid RuizHead of Digital Supply Chain Strategy & Execution Follow DavidWill RobinsonConference DirectorLogiPharmaFollow WillMethodology
